Dysbiosis Enhancing Linkage Towards Association with Canine Hemangiosarcoma (DEL-HSA)Open
Hemangiosarcoma (HSA) is an aggressive cancer in dogs and carries a poor prognosis. There are limited therapeutic options for the treatment of HSA, with none currently providing a significant opportunity for long-term survival.
The Intestinal Dysbiosis Program is investigating the associations between the presence of dysbiosis and the development and metastasis of HSA.
- Dogs being concurrently enrolled in the Ethos-PUSH trial.